Magnesium Overview Magnesium intake in Australia Stress: The elevation in catecholamine levels
Around one third of Australians over the age of 18
associated with anxiety may be responsible for
do not get their recommended dietary intake (RDI)
increased magnesium urinary excretion and
of magnesium,1 and on average, the magnesium
decreased magnesium plasma concentrations.6
consumption levels of Australian men and women are
Ageing: Factors that may contribute to inadequate
magnesium levels in the elderly include an increased
A 2001 analysis of data collected from Australian indi-
risk of inadequate magnesium intake, which may
viduals aged ≥ 65 years as part of the National Nutri-
be due to low appetite, poor senses of taste and
tion Survey 1995 highlights the insufficiency of dietary
smell, dental problems, and issues shopping for and
magnesium in this age group, demonstrating that
preparing meals.8 In addition, magnesium metabolism
47.7% of males in this age group had dietary intakes
may change with ageing: urinary magnesium
of magnesium lower than the RDI (320 mg/day), with
excretion tends to increase, and intestinal absorption
11.6% consuming less than 70% of the RDI. Females
in this age group were even more likely to have low
intakes, with 55.5% consuming less than the RDI (270
Other factors: Other risk factors for magnesium
mg) and 13.6% consuming less than 70% of it.
depletion include dietary factors (for example
RDIs for magnesium have since been increased to
high intakes of salt, caffeine or alcohol), endocrine
400-420 mg/day for adult men and 310-320 mg/day
disorders (including diabetes), renal disorders, and
for adult women, so it is possible that current dietary
the use of certain medications, including proton
shortfalls are even more significant than these statis-
pump inhibitors, corticosteroids, loop diuretics, and
The authors concluded that low nutrient intakes
Magnesium deficiency signs
in the Australian elderly could generally be attrib-
uted to poor quality diets that were low in nutri-
Magnesium deficiency signs may include fatigue,
ent density and/or the quantity of food eaten.3
muscle cramps, poor concentration and attention
span, hyper-irritability, excitability and vertigo.10,11
Symptoms of hypomagnesaemia such as anorexia,
nausea, tremor, apathy and confusion do not typically
occur until plasma concentrations fall below than 0.5
mmol/L. In such cases secondary hypokalaemia and hypocalcaemia may also be present.9
Testing for magnesium deficiency
Determining magnesium status can be problematic
as there are no simple, quick, and reliable laboratory
Although magnesium serum concentration is the most
commonly used test, magnesium is predominantly
an intracellular ion, and normal serum values (0.8-
Chart 1: Average magnesium intakes in Australia by age compared to
1.0 mmol/L)12 are an unreliable measure of both
RDI (National Nutrition Survey 1995)2
intracellular availability and total body levels.8,9,13 Other
tests used include red blood cell, muscle tissue, and
Factors affecting magnesium levels
urinary excretion levels, but like serum magnesium
levels, these biomarkers are not considered reliable
Aside from inadequate dietary intake,2,3 strenuous
exercise,4,5 stress6 and poor absorption due to ageing7
may also lower magnesium in the body. Exercise: Strenuous exercise (even at submaximal
levels) is believed to contribute to magnesium deficit via
increased magnesium losses in urine and sweat, which
may increase magnesium requirements by 10-20%.4,5
Information for healthcare professionals only. Not for public distribution.
As a consequence, it has been suggested that
Absorption and bioavailability after
clinical signs and symptoms and response to
magnesium supplementation
supplementation may be the best indications of
The absorption of magnesium from supplements
magnesium insufficiency. A high degree of suspicion
depends on a variety of factors, including the
is necessary, especially in patients at high risk of
status of magnesium stores in the body, the type of
deficiency (e.g. those affected by diabetes types I or
magnesium salt used, and whether the mineral is
II, diarrhoea, alcoholism, inflammatory bowel disease,
or taking medicines known to deplete magnesium
The bioavailability of magnesium from different
magnesium salts is thought to depend on their
Additionally, it should be noted that low intracellular
aqueous solubility. Organic salts of magnesium such
levels of magnesium may still be present when serum
as magnesium L-aspartate are the most water-
magnesium concentration is normal, particularly
soluble, and have been shown to have a greater oral
in patients with unexplained hypocalcaemia or
absorption and bioavailability than less soluble salts
refractory hypokalaemia.16 Up to a third of patients with
such as magnesium hydroxide, magnesium oxide,
hypokalaemia, hypophosphataemia, hypocalcaemia
magnesium sulphate and magnesium carbonate.22
or hyponatraemia can be expected to have
co-existing tissue magnesium depletion.13
A 2001 crossover study compared the relative
bioavailability of magnesium from magnesium
Magnesium – physiological functions
aspartate, magnesium lactate, magnesium chloride
Magnesium helps to build and maintain normal
and magnesium oxide in 16 healthy subjects by
measuring urinary magnesium excretion.22 As
have linked increased magnesium consumption with
summarised in Table 1, magnesium aspartate,
magnesium chloride, and magnesium lactate
displayed similar levels of bioavailability, and
Magnesium is an important modulator of intracellular
magnesium oxide was considerably less bioavailable
ion concentrations and is involved in the active
(approximately twofold) than magnesium from
transport of other ions (for example calcium and
other salts. At the dose administered, no adverse
potassium) across cell membranes. Consequently
it helps to maintain normal functioning of skeletal,
smooth and cardiac muscle, including muscle
contraction and heart rhythm.4,7,8,11,17,18
Preparation Change from p value magnesium
Magnesium is sometimes referred to as ‘nature’s
(mg/day) (mg/day) mean ± SD mean ± SD
physiological calcium channel blocker’.8,20 When
magnesium levels are low, intracellular calcium
rises. Amongst other consequences, this affects
muscle contraction and relaxation and may result in
Due to its actions as a calcium antagonist, magnesium
also reduces neuron excitability, inhibits acetylcholine
release at the neuromuscular junction, and reduces
the effect of the excitatory central nervous system
neurotransmitter N-methyl-D-aspartate. Like other
Table 1: Urinary magnesium excretion following administration of
calcium antagonists it acts as a vasodilator and
magnesium aspartate, magnesium lactate, magnesium chloride and
magnesium oxide in healthy human volunteers.22
Magnesium contributes to normal energy metabolism,8,18,20
in part because it forms a complex with adenosine
A 2007 article, published in Australian Prescriber,
triphosphate (ATP), which provides energy for almost
recommended that magnesium deficient patients
and those with asymptomatic hypomagnesaemia be
to relieve tiredness and fatigue in people with low
treated with oral magnesium supplements, typically
magnesium aspartate. They caution against the
use of higher doses, which may have a laxative
Magnesium helps maintain normal, healthy brain
effect, and stress that the underlying cause for the
function, and in particular, psychological functions.11
hypomagnesaemia should always be determined
In addition, it is involved in protein synthesis and
Information for healthcare professionals only. Not for public distribution. Use with prescription medications
13. Dipalma JR. Magnesium replacement therapy. Am Fam Phys
Proton pump inhibitors: Proton pump inhibitors
14. Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of
may cause hypomagnesaemia if taken long-term
magnesium after administration of magnesium salts to humans. Am J
15. Wu, J, Carter A. Magnesium: the forgotten electrolyte. Australian
Bisphosphonates, chlorpromazine, tetracyc- line and quinolone antibiotics: Magnesium
16. Merck Manual for Health Care Professionals: Disorders of magnesium
may decrease the absorption and efficacy of
concentration (Section: Endocrine and metabolic disorders, Chapters: Electrolyte Disorders). Whitehouse Station, NJ: Merck Sharp & Dohme
these medications. A separation of dosing by at
Corp. Accessed September 2011 from www.merckmanuals.com/
professional/print/endocrine_and_metabolic_disorders/electrolyte_disorders/disorders_of_magnesium_concentration.html
17. Health Canada. Magnesium monograph. Accessed September
Cautions
2011 from webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq. do?id=135&lang=eng
18. European Food Safety Authority. Scientific opinion on the substantiation
orally in people with normal renal function.
of health claims related to magnesium and electrolyte balance (ID 238),
Oral magnesium has been given in doses of
energy-yielding metabolism (ID 240, 247, 248), neurotransmission and muscle contraction including heart muscle (ID 241, 242), cell division
600-1,200 mg daily for four months without major
(ID 365), maintenance of bone (ID 239), maintenance of teeth (ID 239),
adverse effects. Toxicity is rare, but is more likely
blood coagulation (ID 357) and protein synthesis (ID 364) pursuant
to occur in circumstances such as high-dose
to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009;7(9):1216
intravenous administration and in patients with
19. Tucker KL, Hannan MT, Chen H, et al. Potassium, magnesium and fruit
and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999;69:727-36
Diarrhoea and gastric irritation may occur at
20. Volpe SL. ‘Magnesium’. Bowman BA, Russell RM (eds) Present
excessive doses (typically >350 mg elemental
knowledge in nutrition, 9th ed, Vol 1. Washington, DC: International
magnesium/day). Individuals with impaired
renal function are at higher risk of experiencing
21. Natural Medicines Comprehensive Database. Magnesium monograph.
Accessed September 2011 from naturaldatabase.therapeuticresearch.
diarrhoea with magnesium supplementation7,10
22. Anton R, Barlow S, Boskou D, et al. Opinion of the Scientific Panel on
Food Additives, Flavourings, Processing Aids and materials in Contact with Food on a request from the Commission related to Magnesium
References
Aspartate as a mineral substance in when used as a source of
1. Australian Bureau of Statistics. National Nutritional Survey 1995.
magnesium in dietary foods for special medical purposes. Question
Adjusted nutrient intakes in comparison to RDI (unpublished data).
number EFSA-Q-2004-066. EFSA Journal 2005;167:1-6.
2. McLennan W, Podger A. National nutrition survey: Nutrient intakes
23. Natural Standard. Magnesium monograph. Accessed October 2011
and physical measures, Australia, 1995. Canberra: Commonwealth of
3. Bannerman E, Margarey AM, Daniels LA. Evaluation of micronutrient
intakes of older Australians: the National Nutrition Survey – 1995. J Nutr, Health Aging 2001;5(4) :243-7
4. Laires MJ, Monteiro CP, Bicho M. Role of cellular magnesium in health
and human disease. Front in Biosc 2004;9(Jan 1):262-76
5. Nielsen FH, Lukaski HC. Update on the relationship between
magnesium and exercise. Magnes Res 2006;19(3):180-9
6. Grases G, Perez-Castello JA, Sanchis P, et al. Anxiety and stress
among science students. Study of calcium and magnesium alterations. Magnes Res 2006;19(2):102-6
7. Higdon J. Magnesium. An evidence based approach to vitamins and
minerals. New York: Thieme, 2003, pages 148-56
8. Institutes of Medicine. ‘Magnesium’. Dietary reference intakes for
calcium, phosphorus, magnesium, vitamin D and fluoride. Washington: National Academy Press, 1997, pages 190-233
9. Cundy T, Mackay J. Proton pump inhibitors and severe
hypomagnesaemia. Curr Opin Gastroenterol 2011;27(2):180-5
10. Braun L, Cohen M. ‘Magnesium’. Herbs and natural supplements.
11. European Food Safety Authority. Scientific Opinion on the substantiation
of health claims related to magnesium and “hormonal health” (ID 243), reduction of tiredness and fatigue (ID 244), contribution to normal psychological functions (ID 245, 246), maintenance of normal blood glucose concentrations (ID 342), maintenance of normal blood pressure (ID 344, 366, 379), protection of DNA, proteins and lipids from oxidative damage (ID 351), maintenance of the normal function of the immune system (ID 352), maintenance of normal blood pressure during pregnancy (ID 367), resistance to mental stress (ID 375, 381), reduction of gastric acid levels (ID 376), maintenance of normal fat metabolism (ID 378) and maintenance of normal muscle contraction (ID 380, ID 3083) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1807
12. Hughes J. ‘Magnesium’. Use of laboratory test data. Pharmaceutical
Information for healthcare professionals only. Not for public distribution. Magnesium Summary Magnesium contributes to: Symptoms may include:6,10,14
Maintenance of healthy bones and teeth1,2,4
Normal brain and psychological functions6
Who is at risk of low magnesium levels?
Many Australians have low magnesium levels. For
example, at least 48% of men and 56% of women
65 years may not obtain the RDI from their
Symptoms of hypomagnesaemia do not typically
occur until plasma concentrations fall below 0.5
mmol/L. In such cases secondary hypokalaemia and
Relationship to prescribed medicines
Magnesium may decrease the absorption and
efficacy of tetracycline, quinolone antibiotics and
bisphosphonates, and separation of dosing by at
Factors that may contribute to low magnesium status References
1. Health Canada.Magnesium monograph. Accessed September 2011
2. EFSA. EFSA Journal 2009;7(9):12163. Laires MJ, et al. Frontiers in Bioscience 2004;9(Jan 1):262-76
High intakes of salt, caffeine or alcohol10
4. Institutes of Medicine. ‘Magnesium’. Dietary Reference Intakes for
calcium, phosphorus, magnesium, vitamin D and fluoride. Washington:
5. Volpe SL. Magnesium, in Bowman BA, Russell RM (eds). Present
Knowledge In Nutrition, 9th Ed, Vol 1. Washington, DC: International Life Sciences Institute, 2006. 400-8
6. EFSA. EFSA Journal 2010;8(10):18077. Australian Bureau of Statistics. National Nutrition Survey 1995
Identifying magnesium insufficiency
(unpublished data). `Adjusted nutrient intakes in comparison to RDI’
8. Bannerman E, et al. J Nutr Health Aging. 2001;5(4)
Determining magnesium status can be problematic,
9. Dipalma JR. AFP Clinical Pharmacology 1990;42(1):173-6
as there are no simple, quick and reliable laboratory
10. Braun L, Cohen M. Herbs and Natural Supplements. Australia: Elsevier.
tests. Magnesium serum concentration is the most
11. Nielsen FH, Lukaski HC. Magnes Res 2006;19(3):180-9
commonly used test, but normal serum values (0.8-
12. Grases G, et al. Magnes Res 2006;19:2102–6
1.0 mmol/L54) are an unreliable measure of both
13. Higdon J. An Evidence-Based Approach to Vitamins and Minerals.
intracellular availability and total body levels.
14. Cundy T, Mackay J. Curr Opin Gastroenterol 2011;27(2):180-5
Consequently, clinical signs and symptoms and
15. Hughes J. ‘Magnesium’. Use of laboratory test data. Pharmaceutical
response to supplementation may represent better
16. Wu, J, Carter A. Australian Prescriber 2007;30(4):102-5
indications of magnesium insufficiency.9,16
17. Anton R, et al. EFSA Journal 2005;167:1-6. 57. Natural Medicines
Comprehensive Database. Lactobacillus monograph. Accessed October 2011 http://naturaldatabase.therapeuticresearch.com
18. Hawrelak J, Myers S. Altern Med Rev 2004; 9 (2):180-97
Prescribing tip: Water-soluble organic
19. Sullivan A, et al. Lancet Infect Dis 2001;1:101-14
magnesium salts such as magnesium L-aspartate
20. Lionetti E, et al. Aliment Pharmacol Ther. 2006;24:1461-821. Reuter G. Curr Issues Intest Microbiol. 2001;2(2):43-53
have been shown to have better oral absorption
22. Casas IA, et al. Microbial Ecol Health Disease 2000;12:247–85
and bioavailability than less soluble salts such
23. BioGaia. Clinical evidence. Accessed October 2011 www.biogaia.
as magnesium hydroxide, magnesium oxide,
24. Cimperman L et al. J Clin Gastroenterol 2011; May 5 [Epub ahead of
magnesium sulphate and magnesium carbonate.17
25. Francavilla R et al. Helicobacter 2008;13:127–34
Information for healthcare professionals only. Not for public distribution.
BALTIMORE COUNTY PUBLIC SCHOOLS Office of Health Services Consent for Administration of Approved Discretionary Medications and Health Contact Information Student Name: ______________________________________________________ Date of Birth: ___________________ School: _______________________________________________ Grade /Teacher: ______________________________ Allergies (inc